SHTG Daily Digest — Weiss Lab
A quiet cycle on both fronts — no new top-tier lipid papers cleared the bar (the one journal hit, a Lancet D&E retrospective, was already covered Tuesday), and no fresh trade-press stories landed in the 5-day window, leaving the competitive backdrop dominated by the countdown to the FDA's June 30 decision on olezarsen in severe hypertriglyceridemia.
21 episodes
Comments
0Be the first to comment
Sign up now and become a member of the SHTG Daily Digest — Weiss Lab community!